-
Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan
18 Jun 2025 02:29 GMT
… used to treat multiple cancer types, including melanoma, non-small … patient access to life-saving treatments.
Under the agreement, … ’s blockbuster anti-inflammatory drug. The decision reversed a … Stelara), helping to lower treatment costs and expand access for …
-
Parkinson's Discovery Suggests We Could Have an FDA-Approved Treatment Already
17 Jun 2025 23:54 GMT
… .
Promisingly, an FDA-approved cancer drug that targets another … This suggests a potential treatment for Parkinson's … targeting this interaction with drugs could significantly slow … mice the drug nivolumab/relatlimab, a melanoma medication that contains …
-
Shorter immunotherapy regimens may be sufficient for advanced melanoma
17 Jun 2025 22:29 GMT
… is the gold standard treatment for advanced melanoma, but we do … , told Healio. “The drugs are licensed to give until … to immediately stop treatment or to continue treatment for at … of immunotherapy for advanced melanoma, the trial was closed early because …
-
Lutris Pharma To Present Data From Its Phase 2 Trial Of LUT014 Gel For The Treatment Of Patients With EGFRI-Induced Acneiform Rash At The ESMO Gastrointestinal Cancers Congress 2025
17 Jun 2025 13:57 GMT
… phase 2 randomized clinical trial of lead compound, LUT014 … progressed on prior chemotherapy treatments. Although effective as anti … human cancers such as melanoma, blocking this pathway leads … dermatitis.
About Lutris Pharma
Lutris Pharma is a clinical stage …
-
Sona Engages Clinical Trial Clinic For First-In-Human Early Feasibility Study Of Its THT Cancer Therapy
17 Jun 2025 00:04 GMT
… early feasibility study clinical trial of its Targeted Hyperthermia … THT treatment for up to ten patients with advanced melanoma.
… trials in melanoma for tier-one global pharmaceutical companies, we … tumor perfusion – thus enabling drugs to reach all tumor …
-
Uveal Melanoma (UM): Charting the Future of Innovation in a Rare Eye Cancer | Competitive Intelligence
16 Jun 2025 17:00 GMT
… Melanoma
1. KIMMTRAK® (tebentafusp-tebn) – Immunocore
• FDA … – Fusion Pharmaceuticals/;AstraZeneca … melanoma
Target Opportunity Profile (TOP)
To outcompete approved therapies, emerging drugs … melanoma has long been underserved with limited treatment …
-
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology
16 Jun 2025 12:30 GMT
… the treatment of various forms of cancer, including melanoma
Fosun Pharma- … with the potential to treat devastating cancers, is the … editing, and AI-powered drug discovery. This multidimensional approach … of unfavorable new clinical trial data and further analyses …
-
Is this FTSE 100 pharma gem now a brilliant bargain?
16 Jun 2025 09:56 GMT
FTSE 100 pharmaceutical giant GSK (LSE: GSK … by the US on pharmaceutical imports. This has not … the US Food and Drug Administration. These included its … Nucala COPD treatment, Blennrep multiple melanoma drug, and Depemokimab asthma treatment.
GSK announced …
-
Biogen leads Cannes Lions Pharma shortlist, with BMS, Novartis cracking Health & Wellness category
16 Jun 2025 08:29 GMT
… Squibb and Novartis led pharma representation.
As happens every … drug Skyclarys in its $7.3 billion takeover of Reata Pharmaceuticals … to raise awareness of melanoma. Novartis was shortlisted for … Monday evening. Check Fierce Pharma Marketing Tuesday to learn …
-
Jersey woman runs for melanoma awareness in memory of her mother
16 Jun 2025 07:12 GMT
… then, the melanoma had spread.
“Unfortunately, when melanoma makes it inside … incredibly hard to completely treat once it is in … serious – and preventable – melanoma can be.
“Melanoma is more deadly than … of pain, worry, and treatment, I can push through 31 …